Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Thyroid peroxidase antibodies are associated with an increased risk of miscarriage and preterm birth, even when thyroid function is normal. Small trials indicate that the use of levothyroxine could reduce the incidence of such adverse outcomes. METHODS: We conducted a double-blind, placebo-controlled trial to investigate whether levothyroxine treatment would increase live-birth rates among euthyroid women who had thyroid peroxidase antibodies and a history of miscarriage or infertility. A total of 19,585 women from 49 hospitals in the United Kingdom underwent testing for thyroid peroxidase antibodies and thyroid function. We randomly assigned 952 women to receive either 50 μg once daily of levothyroxine (476 women) or placebo (476 women) before conception through the end of pregnancy. The primary outcome was live birth after at least 34 weeks of gestation. RESULTS: The follow-up rate for the primary outcome was 98.7% (940 of 952 women). A total of 266 of 470 women in the levothyroxine group (56.6%) and 274 of 470 women in the placebo group (58.3%) became pregnant. The live-birth rate was 37.4% (176 of 470 women) in the levothyroxine group and 37.9% (178 of 470 women) in the placebo group (relative risk, 0.97; 95% confidence interval [CI], 0.83 to 1.14, P = 0.74; absolute difference, -0.4 percentage points; 95% CI, -6.6 to 5.8). There were no significant between-group differences in other pregnancy outcomes, including pregnancy loss or preterm birth, or in neonatal outcomes. Serious adverse events occurred in 5.9% of women in the levothyroxine group and 3.8% in the placebo group (P = 0.14). CONCLUSIONS: The use of levothyroxine in euthyroid women with thyroid peroxidase antibodies did not result in a higher rate of live births than placebo. (Funded by the United Kingdom National Institute for Health Research; TABLET Current Controlled Trials number, ISRCTN15948785.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, there were insufficient data to perform a subgroup analysis of women with recurrent miscarriage, TPO antibodies and SCH.192”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [192]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Negro, R., Formoso, G., Mangieri, T., Pezzarossa, A., Dazzi, D., & Hassan, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1603 · Cited by 759
Thangaratinam, S., Tan, A., Knox, E., Kilby, M. D., Franklyn, J., & Coomarasamy, A. (2011) · BMJ · doi:10.1136/bmj.d2616 · Cited by 604
Self-citationWang, H., Gao, H., Chi, H., Zeng, L., Xiao, W., Wang, Y., Li, R., Liu, P., Wang, C., Tian, Q., et al. (2017) · JAMA · doi:10.1001/jama.2017.18249 · Cited by 236
Negro, R., Mangieri, T., Coppola, L., Presicce, G., Casavola, E. C., Gismondi, R., Locorotondo, G., Caroli, P., Pezzarossa, A., Dazzi, D., et al. (2005) · Human Reproduction · doi:10.1093/humrep/deh843 · Cited by 233
Research works printed but not linked: 2
- 2. NICE. Preterm labour and birth: guidance. Context. November 2015 (https:// www .nice .org .uk/ guidance/ ng25/ chapter/ context).
- 10. Fertility problems: assessment and treatment. NICE clinical guideline 156. - London: National Institute for Health and Care Excellence, 2013.
Cited by
Items 101–200 of 316
Thyroid function and IVF outcome for different indications of subfertility
van Driel-Delprat, C. C. R., van Dam, E. W. C. M., van de Ven, P. M., Aissa, K., ter Haar, M. K., Feenstra, Y., de Roos, A., Beelen, G., Schats, R., & Lambalk, C. B. (2021) · Reproduction and Fertility · doi:10.1530/raf-20-0065 · Cited by 14
Li, G., Liu, Y., Su, X., Huang, S., Liu, X., & Du, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.874975 · Cited by 13
Wu, M. Y., Chi, C., Yang, Y., Guo, S., Li, T., Gu, M., Zhang, T., Gao, H., Liu, R., & Yin, C. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04923-5 · Cited by 13
Universal screening for thyroid disease SHOULD NOT be recommended before and during pregnancy
van der Spek, A. H., & Bisschop, P. H. L. T. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101429 · Cited by 15
Allotey, J., Archer, L., Coomar, D., Snell, K. I. E., Smuk, M., Oakey, L. A., Haqnawaz, S., Betrán, A. P., Chappell, L. C., Ganzevoort, W., et al. (2024) · Health Technology Assessment · doi:10.3310/dabw4814 · Cited by 12
Self-citationXie, J., Gu, A., He, H., Zhao, Q., Yu, Y., Chen, J., Cheng, Z., Zhou, P., Zhou, Q., & Jin, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1185147 · Cited by 13
“Randomized controlled studies (RCTs) demonstrated that the use of levothyroxine had no improvement on ART outcomes in infertile AITD patients (45, 46), which suggested that AITD-associated infertility is a non-endocrine autoimmune disease.”
BackgroundDoulaveris, G., Vani, K., Saccone, G., Chauhan, S. P., & Berghella, V. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100509 · Cited by 14
Zhang, L., Du, Y., Zhou, J., Li, J., Shen, H., Liu, Y., Liu, C., & Qiao, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1215469 · Cited by 16
“…2019 concluded that that the use of levothyroxine in euthyroid women with thyroid peroxidase antibodies did not result in a higher rate of live births than placebo in normal population (10), and the preconception use of levothyroxine in recurrent miscarriage population still need further research.”
BackgroundSierra, S., Min, J. K., Saumet, J., Shapiro, H. M., Sylvestre, C. V., Roberts, J., Liu, K. E., Buckett, W. M., Vélez, M. P., & MAHUTTE, N. G. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104456 · Cited by 16
Mustafa, M., Ali, E., McGowan, A., McCabe, L., Hegedüs, L., Attanasio, R., Nagy, E. V., Papini, E., Perros, P., & Moran, C. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-022-03235-z · Cited by 11
“In 2019, a large UK trial of thyroxine use in euthyroid women with positive thyroid peroxidase autoantibodies did not show an increase in live birth rate compared to placebo [42].”
BackgroundSitoris, G., Veltri, F., Jelloul, E., Kleynen, P., Rozenberg, S., & Poppe, K. G. (2023) · Thyroid Research · doi:10.1186/s13044-023-00171-7 · Cited by 14
“show a beneficial impact of LT4 on life birth and recurrent miscarriage rates in euthyroid women with TAI [3, 4].”
BackgroundLafontaine, N., Brown, S. J., Perros, P., Papini, E., Nagy, E. V., Attanasio, R., Hegedűs, L. D., & Walsh, J. P. (2024) · Clinical Endocrinology · doi:10.1111/cen.15049 · Cited by 13
“33 19 Only eleven percent of respondents considered prescribing thyroid hormones for a simple goitre growing over time, which is consistent with clinically insignificant benefit and the risks associated with lowering TSH. 34 22 Reassuringly, use of thyroid hormone for euthyroid patients with…”
BackgroundLi, J., Yu, J., Huang, Y., Xie, B., Hu, Q., Ma, N., Qin, R., Luo, J., Wu, H., Liao, M., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1359210 · Cited by 13
“Trial immunotherapy has garnered considerable attention in the realm of infertility treatment, particularly considering a burgeoning body of research indicating that levothyroxine monotherapy may not suf fi ce to enhance fertility or optimize pregnancy outcomes (47 – 49).”
BackgroundZhang, Y., Zhang, Y., Su, Z., Ren, B., Yu, S., Li, W., Xu, N., & Lou, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1376179 · Cited by 10
A Review of Autoimmune Thyroid Diseases and Their Complex Interplay with Female Fertility
Carafone, L. E., Knutson, A. J., & Gigliotti, B. J. (2024) · Seminars in Reproductive Medicine · doi:10.1055/s-0044-1795160 · Cited by 12
Zhou, P., Yao, Q., Zhao, Q., Yang, L., Yu, Y., Xie, J., Feng, C., Zhou, L., & Jin, M. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04532-2 · Cited by 11
“In the past few years following the publication of the 2017 guidelines, two large RCTs assessing the value of levothyroxine on pregnancy outcomes in euthyroid TPOAb positive women reported that the use of this drug did not significantly improve miscarriage rate and live birth rate [22, 23].”
BackgroundYu, M., Long, Y., Wang, Y., Zhang, R. X., & Tao, L. (2023) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2023.2233039 · Cited by 11
“Some studies have reported that there was no effect of levothyroxine on the live birth rate in RPL women with TPOAb þ [9,10], whereas others suggested that levothyroxine therapy increased the odds of live birth [11].”
BackgroundResultThyroid Function Test Abnormalities During Pregnancy
Cappola, A. R., & Casey, B. M. (2019) · JAMA · doi:10.1001/jama.2019.10159 · Cited by 11
Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception
Sarne, D. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1906509 · Cited by 10
Negro, R., Žarković, M., Attanasio, R., Hegedűs, L. D., Nagy, E. V., Papini, E., Akarsu, E., Alevizaki, M. K., Ayvaz, G., Bednarczuk, T., et al. (2024) · Clinical Endocrinology · doi:10.1111/cen.15099 · Cited by 11
“23,24 Data showed that in the placebo group 7% – 9% of TPOAb ‐ positive women developed hypothyroidism and that those who developed hypothyroidism had a mean TSH concentration higher than those who remained euthyroid (3.0 vs. 2.0mIU/L).”
InfluentialWang, J., Li, J., Zhang, J., Liu, A., Yang, W., Zhai, X., Teng, W., Li, Y., & Shan, Z. (2025) · Human Reproduction Open · doi:10.1093/hropen/hoaf036 · Cited by 10
“…nine studies used a fixed initial LT4 dose (25–100 μ g/day), with 50 μ g/day being the most common starting dose (Zhang et al. , 2016; Casey et al. , 2017; Li and Dai, 2018; Bai, 2019; Dhillon-Smith et al. , 2019; Shu et al. , 2019; Wang and Chen, 2020; Wang et al. , 2021; Leng et al. , 2022).”
Liu, Y., Osinga, J. A. J., Feldt‐Rasmussen, U., Vrijkotte, T. G. M., Taylor, P. N., Aminorroaya, A., Ashoor, G., Bliddal, S., Chen, L., Vaidya, B., et al. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103491 · Cited by 9
“Third, they could be considered for thyroid function testing upon planning a future fertility treatment [37 – 39], or during a subsequent pregnancy [11].”
Actualización sobre patología tiroidea durante el embarazo: hipotiroidismo e hipertiroidismo
Vaglio, R. F., & Céspedes, N. P. (2020) · Revista Medica Sinergia · doi:10.31434/rms.v5i10.491 · Cited by 13
Ayvaz, G., Akarsu, E., Attanasio, R., Hegedűs, L. D., Nagy, E. V., Papini, E., & Perros, P. (2022) · Endocrinology research and practice. · doi:10.5152/tjem.2022.22024 · Cited by 10
Nedeljković-Beleslin, B., Attanasio, R., Hegedűs, L. D., Nagy, E. V., Negro, R., Papini, E., Perros, P., Ćirić, J., & Žarković, M. (2022) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh211221110n · Cited by 11
Thyroid Function and Conception
Chen, A., Leung, A. M., & Korevaar, T. I. M. (2019) · New England Journal of Medicine · doi:10.1056/nejmclde1902637 · Cited by 9
Hypothyroidism and pregnancy: still a controversial issue
Berković, M. C., Mahečić, D. H., Radošević, J. M., Strinović, M., & Bilić-Čurčić, I. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1740202 · Cited by 9
Thyroid pathology and female fertility: Myth or reality?
Vannucchi, G. M., Persani, L., & Fugazzola, L. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.05.001 · Cited by 13
Liu, Q., Qiu, Y., Jiang, J., Long, S., Zhu, C., Chen, G., & Wen, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1425639 · Cited by 8
Dhillon‐Smith, R. K., Middleton, L. J., Sunner, K. K., Cheed, V., Baker, K., Farrell-Carver, S., Bender-Atik, R., Agrawal, R., Bhatia, K., Edi-Osagie, E. C. O., et al. (2019) · Efficacy and Mechanism Evaluation · doi:10.3310/eme06110 · Cited by 10
“57 BMI (kg/m(2)) ≥ 25 41/132 (31) 39/133 (29) 1.”
BackgroundInfluentialSelf-citationGeneral infertility workup in times of high assisted reproductive technology efficacy
Polyzos, N. P., Ayoubi, J. M., & Pirtea, P. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.05.019 · Cited by 9
Euthyroid Thyroperoxidase Antibody Positivity during Pregnancy, to Treat or Not to Treat?
Korevaar, T. I. M. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.301 · Cited by 8
“We have now learned from three well-performed randomized trial that there is no benefit of preconception levothyroxine treatment for euthyroid TPOAb positive women [25-27].”
BackgroundMoleti, M., Alibrandi, A., Mauro, M. D., Paola, G., Perdichizzi, L. G., Granese, R., Giacobbe, A., Scilipoti, A., Ragonese, M., Ercoli, A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac748 · Cited by 8
Puga, F., Simões, H., Melo, M., Attanasio, R., Hegedűs, L. D., Nagy, E. V., Papini, E., Perros, P., & Freitas, C. (2022) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ao210050 · Cited by 11
Scher, J., Dabao, C., & Rukat, C. E. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70042 · Cited by 7
“However, large recent controlled studies have shown that using levothyroxine is no more effective than a placebo [1, 4].”
Thyroid disorders and female infertility
Unuane, D., Velkeniers, B., & Poppe, K. G. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag039 · Cited by 8
Subclinical Hypothyroidism and Thyroid Autoimmunity in Pregnancy
Maraka, S., & Dosiou, C. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.05.010 · Cited by 7
Galofré, J. C., Attanasio, R., Hegedűs, L. D., Nagy, E. V., Negro, R., Papini, E., Perros, P., & Díez, J. J. (2022) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2022.07.001 · Cited by 16
Pregnancy-related reference intervals for serum thyrotropin based on real-life clinical data
Canovi, S., Vezzani, S., Polese, A., Frasoldati, A., Schiatti, C., Preda, C., Zini, M., Vitiello, A., Foracchia, M., Comitini, G., et al. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1756251 · Cited by 7
de Carvalho, B. R., Nácul, A. P., Benetti‐Pinto, C. L., Silva, A. C. J. D. S. R. E., Soares, J. M., Maciel, G. A. R., & Baracat, E. C. (2020) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0040-1714133 · Cited by 10
Lyko, C., Blum, M. R., Abolhassani, N., Stuber, M. J., Giovane, C. D., Feller, M., Moutzouri, E., Oberle, J., Jungo, K. T., Collet, T., et al. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13544 · Cited by 10
Treatment of subclinical hypothyroidism: assessing when treatment is likely to be beneficial
Leng, O., & Razvi, S. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1738924 · Cited by 9
Amiri, M., Nazarpour, S., Tehrani, F. R., Sheidaei, A., & Azizi, F. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01738-7 · Cited by 7
Subclinical hypothyroidism in pregnancy: an evolving and controversial landscape
Aberle, L. S., & Nguyen, C. T. (2025) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000001019 · Cited by 6
Thyroid Gland and Pregnancy – Clinical Update
Mladenović, V., Shah, R., Medenica, S., Dutta, P. R., Zanković, N., Akšam, S. S., Ghosh, J., Hussain, M., & Gluvic, Z. M. (2025) · Hormone and Metabolic Research · doi:10.1055/a-2604-4177 · Cited by 7
“Three large randomized controlled trials, POSTAL, TABLET, and T4LIFE, have shown no obstetrical benefit of LT supplementation [34, 35, 62, 66].”
Committee Opinion No. 407: Thyroid Disease and Infertility
Donovan, L., Cockwell, H., Tallon, N., & Yamamoto, J. M. (2020) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2020.08.004 · Cited by 6
Korevaar, T. I. M., & Dhillon‐Smith, R. K. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00079-1 · Cited by 7
Self-citationChen, J., Jiao, X., Zhang, L., Zhang, M., Zeng, L., Liu, D., Li, H., Zou, K., Wei, Q., & Zhang, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1054935 · Cited by 9
“11 studies (Negro et al., 2005; Negro et al., 2006; Revelli et al., 2009; Lepoutre et al., 2012; Mosaddegh et al., 2012; Negro et al., 2016; Nazarpour et al., 2017; Wang et al., 2017; Dhillon-Smith et al., 2019; Dal Lago et al., 2021; Tsunemi et al., 2021) comprising 2,901 euthyroid pregnant women with thyroid autoimm…”
BackgroundGeyter, C. D., Matt, L., Geyter, I. D., Moffat, R., & Meier, C. (2023) · Human Reproduction Open · doi:10.1093/hropen/hoad038 · Cited by 7
“However, recent randomized clinical trials have not demonstrated higher live birth numbers resulting from treatment with thyroxine in euthyroid women carrying anti-TPO (Dhillon-Smith et al. , 2019), even in cases with recurrent pregnancy loss (Van Dijk et al. , 2022).”
Controversies in thyroid disease management in pregnancy
Singh, P., & Boelaert, K. (2025) · Clinical Medicine · doi:10.1016/j.clinme.2025.100287 · Cited by 8
Self-citationErol, S. A., Çağlar, A. T., Üstün, Y. E., & Ozgu-Erdinc, A. S. (2022) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-022-01151-y · Cited by 6
“6%), or adverse perinatal and neonatal outcomes between the antiTPO positive group (n = 476) who received 50 g/day LT4 treatment from conception to the end of pregnancy and the non-treated group (n = 476) in a placebo-controlled, doubleblind study involving 19,585 women undergoing anti-TPO screening for a history of m…”
BackgroundWu, J., Peng, T., Xie, F., & Li, M. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04806-9 · Cited by 7
“This might explain the failure of levothyroxine in lowing preterm birth risk for women positive for TPOAb before conception in a previous intervention study [29].”
BackgroundAn Ion-Competition Assisted Fiber Optic Plasmonic DNA Biosensing Platform for Iodide Detection
Duan, Y., Li, J., Jin, J., Xu, H., Wang, F., Shi, J., Tong, X., Wang, Q., Zhang, Y., Peng, W. B., et al. (2024) · IEEE Sensors Journal · doi:10.1109/jsen.2024.3364376 · Cited by 6
“I ODIDE ion, a biologically significant anion, serves as an essential trace element for regulating human growth and thyroid function [1], [2], playing a vital role in maintaining organism health.”
BackgroundSubclinical thyroid diseases and isolated hypothyroxinemia during pregnancy
Locantore, P., Corsello, A., Policola, C., & Pontecorvi, A. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03391-5 · Cited by 6
Yi, K. H., Ahn, H. Y., Kim, J. H., Park, S. Y., Yoo, W. S., Jung, K. Y., Lee, E. K., Park, Y. J., Kim, S. W., Yim, C. H., et al. (2023) · International Journal of Thyroidology · doi:10.11106/ijt.2023.16.1.51 · Cited by 7
The Value of Parental Karyotyping in Recurrent Pregnancy Loss Lies in Individual Risk Assessments
Popescu‐Hobeanu, G., Sosoi, S. S., Cucu, M., Streață, I., Dobrescu, A., Pleşea, I. E., Costache, A. L., Iordache, A., Petre-Mandache, B., Tudorache, Ş., et al. (2024) · Medicina · doi:10.3390/medicina60111778 · Cited by 5
van Driel-Delprat, C. R., van Dam, E., van de Ven, P. M., Aissa, K., ter Haar, M., Feenstra, Y., de Roos, A., Beelen, G., Schats, R., & Lambalk, C. B. (2021) · Gynecologic and Obstetric Investigation · doi:10.1159/000518083 · Cited by 6
Guo, L., Wang, X., Wang, Y., Sun, F., Song, Y., Chen, C., Yan, J., & Li, Y. (2023) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2023.05.001 · Cited by 6
The Year in Medical Thyroidology Review: Current Challenges and Future Directions
Busaidy, N. L. (2019) · Thyroid · doi:10.1089/thy.2019.0792 · Cited by 6
Tsunemi, A., Uchida, T., Kuroda, K., Ikemoto, Y., Ochiai, A., Goto, H., Sugiyama, R., Satoh, H., Itakura, A., & Watada, H. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0380 · Cited by 9
Wang, P., Lu, S., Yang, Y. L., Liu, L., Guangpeng, Z., Zhu, J., Niu, D., Wang, Y., & Wang, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1193557 · Cited by 5
“Outcomes Hospitalization time (day) 19 (15-24) 18 (1522) 19 (14-23) 21 (17-26) p<0.”
BackgroundInfluentialWang, R., Liu, L., Zhang, W., Zhang, J., Wang, K., & Wang, F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1711369 · Cited by 10
“Recently, an increasing number of studies have focused on the impact of TAI on fertility and pregnancy outcomes (16 – 18, 23, 29), and have suggested that thyroid hormone replacement does not improve pregnancy outcomes (30, 31).”
Recent Issues Related to Thyroid Disease in Pregnancy
Chung, J. H. (2020) · International Journal of Thyroidology · doi:10.11106/ijt.2020.13.2.85 · Cited by 4
Παππά, Θ., & Alexander, E. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-98777-0_5 · Cited by 4
Zhang, Y., Wu, W., Liu, Y., Guan, Y., Wang, X., & Jia, L. (2020) · International Journal of Endocrinology · doi:10.1155/2020/1056484 · Cited by 4
“On the other hand, according to the two RCTs of high quality, euthyroid women with positive TPO did not benefit from treatment with LT4 [21, 22].”
Zhang, Y., Wu, W., Liu, Y., Guan, Y., Wang, X., & Jia, L. (2020) · International Journal of Endocrinology · doi:10.1155/2020/8829138 · Cited by 4
“On the other hand, according to the two RCTs of high quality, euthyroid women with positive TPO did not benefit from treatment with LT4 [21, 22].”
Shilova, E. S., Borovik, N. V., Popova, P., & Yarmolinskaya, M. I. (2020) · Problems of Endocrinology · doi:10.14341/probl12687 · Cited by 6
Variations in the Antithyroid Antibody Titre During Pregnancy and After Delivery
Li, C., Zhang, N., Zhou, J., Leung, W., Gober, H.-J., Huang, Z., Pan, X., Chen, L., Guan, L., & Wang, L. (2021) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s279975 · Cited by 4
“Dhillon-Smith et al did not find significant differences in the rates of live births with the use of 50 µg levothyroxine (LT4) once daily among euthyroid women with TPOAbs.12 Nazarpour et al found that replacement therapy with LT4 in pregnant women with thyroidstimulating hormone (TSH) concentrations ≥ 4.0 mIU/L was b…”
BackgroundInfluentialPreconception Counseling and Care for Pregnant Women with Thyroid Disease
Dhillon‐Smith, R. K., & Boelaert, K. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.12.005 · Cited by 4
“Subgroup analyses were performed looking at individual populations; no difference was seen for those with a history of miscarriage or those with subfertility.(57)”
MethodResultSelf-citationHe, X., Liu, Y., Wang, H., Sun, W., Lu, Y., Shan, Z., Teng, W., & Li, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.890502 · Cited by 6
Zhang, J., & Lou, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/9086962 · Cited by 4
“In recent years, modern biological immunotherapy has become the fourth treatment mode for malignant tumors [29].”
BackgroundRetractedAkbaş, F., Teke, Z. B., Çavdar, V. C., & Zerdali, H. (2024) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2024.0181 · Cited by 3
Yakob, T., Belay, E., Barata, B. Y., Abraham, A., Assele, D. D., & Israel, E. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04958-4 · Cited by 3
Huang, N., Chen, L., Yan, Z., Zeng, L., Wang, H., Chi, H., & Qiao, J. (2024) · Thyroid · doi:10.1089/thy.2023.0676 · Cited by 3
Levothyroxine supplementation trials in preconception and pregnant women
Man, R., Dhillon‐Smith, R. K., & Korevaar, T. I. M. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf012 · Cited by 3
Self-citationAssessing thyroid peroxidase antibodies in Emirati medical students: a cross-sectional pilot study
Pathan, A., Yasin, J., Sharma, C., Alkaabi, J., & Agha, A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1582933 · Cited by 3
Endocrine disorders in pregnancy
Chong, H. P., Alazzani, H., & Boelaert, K. (2019) · Obstetrics Gynaecology & Reproductive Medicine · doi:10.1016/j.ogrm.2019.08.005 · Cited by 6
Self-citationA Comparison of ATA and Updated ACOG Guidelines for Thyroid Disease in Pregnancy
Pearce, E. N. (2020) · Clinical Thyroidology · doi:10.1089/ct.2020;32.317-320 · Cited by 3
“By contrast, informed by the interim publication of the TABLET randomized clinical trial (8), which found no evidence of benefit in this situation, ACOG recommends against routine testing for serum TPOAbs or treatment for TPOAb-positive euthyroid women (2).”
Вплив автоімунного тиреоїдиту на органи й системи організму (огляд літератури)
SHIDLOVSKYI, V. O., Shidlovskyi, O. V., & Кравців, В. В. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.2.2021.230569 · Cited by 3
Zhang, Y., Liu, Y., Li, Z., & Guan, Y. (2022) · Clinical Endocrinology · doi:10.1111/cen.14802 · Cited by 4
“Dhillon‐Smith et al.(20) investigated the use of LT4 in euthyroid women with thyroid peroxidase antibodies (TPOs) before conception and demonstrated no significant difference in live birth rate.”
BackgroundResultInfluentialPreexisting Thyroid Disease in Pregnancy: A Brief Overview.
Maulik, D., Chuy, V., & Kumar, S. S. (2022) · PubMed Central · Cited by 6
Riis, K. R., Bonnema, S. J., Dreyer, A. F., Glintborg, D., Bilenberg, N., Bleses, D., Trecca, F., & Andersen, M. (2024) · European Thyroid Journal · doi:10.1530/etj-23-0233 · Cited by 3
“These results are in line with similar neutral outcomes in previous trials (52, 53 ).”
Thyroid function monitoring during pregnancy in euthyroid women with thyroid autoimmunity
Kyrilli, A., Corvilain, B., Bliddal, S., Precht, D. H., Feldt‐Rasmussen, U., & Poppe, K. G. (2024) · Endocrine Connections · doi:10.1530/ec-24-0151 · Cited by 5
“…controlled trials, subsequent to the publication of 2017 ATA guidelines, investigated the outcomes of treatment with LT4 and did not find a beneficial effect on pregnancy loss nor on preterm birth in euthyroid women with autoimmunity (TABLET, T4LIFE, Chinese randomized trial) (14 , 15 , 16 ).”
ResultKuokkanen, S., Seungdamrong, A., Santoro, N., Lieman, H., Sun, F., Wild, R. C., Zhang, H., & Pal, L. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.12.005 · Cited by 4
Early and recurrent pregnancy loss
Turocy, J. M., & Williams, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-65399-2.00025-5 · Cited by 4
Tańska, K., Glinicki, P., Rebizant, B., Dudek, P., Zgliczyński, W., & Gietka‐Czernel, M. (2024) · Biomedicines · doi:10.3390/biomedicines12112628 · Cited by 5
Thyroid hormone therapy in a population cohort over two decades indicates persistent overtreatment
Zwanziger, D., Kowall, B., Klose, J. M., Schmidt, B., Stang, A., & Führer, D. (2026) · European Thyroid Journal · doi:10.1530/etj-25-0259 · Cited by 2
“In addition, LT4 treatment has previously been discussed for infertile women with elevated thyroid antibody levels; however, two recent randomized placebo-controlled trials failed to demonstrate a bene fi t of this approach in euthyroid individuals (12, 13, 14).”
Diagnostik und Therapie wiederholter Spontanaborte gemäß S2k-Leitlinie
Nawroth, F., & Tóth, B. (2023) · Die Gynäkologie · doi:10.1007/s00129-022-05039-9 · Cited by 2
Jackson, K. M., & Cooper, D. S. (2019) · Clinical Thyroidology · doi:10.1089/ct.2019;31.410-416 · Cited by 2
Schilddrüse: Fertilität, Schwangerschaft und Laktation
Pilz, S., Theiler‐Schwetz, V., Malle, O., Steinberger, E., Pandis, M., Lerchbaum, E., & Trummer, C. (2020) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-020-00107-8 · Cited by 3
Schilddrüse und Schwangerschaft
Bojunga, J., & Hofbauer, L. (2021) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-021-00196-x · Cited by 2
Preconception Counseling in Patients with Hypothyroidism and/or Thyroid Autoimmunity
Tarna, M., Cima, L., Panaitescu, A. M., Martin, C. S., Sîrbu, A. M., Barbu, C. G., Pavel, B., Serbanica, A. N., & Fica, S. V. (2022) · Medicina · doi:10.3390/medicina58081122 · Cited by 6
“Whilst the evidence for an association between the presence of TPOAb and increased risks of pregnancy loss is compelling, the results of recent RCT of levothyroxine in euthyroid women with underlying autoimmunity could not demonstrate the beneficial effects of LT4 therapy on live birth rate or recurrent pregnancy loss…”
ResultAlexander, E. K. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.31009 · Cited by 2
Levothyroxine for a high‐normal TSH in unexplained infertility
Galbiati, F., Jokar, T. O., Howell, L. M., Li, R., Fourman, L. T., Lee, H., Jeong, J., & Fazeli, P. K. (2023) · Clinical Endocrinology · doi:10.1111/cen.15003 · Cited by 3
“30 Our data also suggest that while treatment with levothyroxine may lead to a slightly higher conception rate, live birth rate is not higher and in fact may be lower in women treated with levothyroxine.”
BackgroundLevothyroxine and thyroid peroxidase antibodies in women with recurrent pregnancy loss
Alecsandru, D., & García-Velasco, J. A. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.12.016 · Cited by 2
Sbracia, M., Scarpellini, F., & Stamenov, G. (2020) · Human Reproduction · doi:10.1093/humrep/deaa078 · Cited by 2
Poppe, K. G. (2022) · Thyroid · doi:10.1089/thy.2022.0370 · Cited by 2
“13,14 Finally, what is now the moral of the Janus-faced meta-analysis story?”
Liu, J., Xie, X., García‐Patterson, A., Asla, Q., Sardà, H., Chico, A. I., Adelantado, J. M., Urgell, E., & Corcoy, R. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07279-z · Cited by 1
“Even in randomized controlled trials, information on GWG is limited or non-existent [13–15].”
Recurrent Pregnancy Loss and Endocrine Dysfunction
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5190-5 · Cited by 1
Eldeiry, L. S., Attanasio, R., Hegedűs, L. D., Negro, R., Papini, E., Perros, P., Gharib, H., Nagy, E. V., Žarković, M., & Garber, J. R. (2025) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2025.10.019 · Cited by 1
“15,39 Despite these limitations, respondent characteristics were similar to nationally published figures and those of other physician surveys on hypothyroidism conducted in the U.S., and the absolute numbers of participants were comparable to other surveys.”
Metadata
- Authors
- Dhillon-Smith, R. K., Middleton, L. J., Sunner, K. K., Cheed, V., Baker, K., Farrell-Carver, S., Bender-Atik, R., Agrawal, R., Bhatia, K., Edi-Osagie, E., Ghobara, T., Gupta, P., Jurkovic, D., Khalaf, Y., MacLean, M., McCabe, C., Mulbagal, K., Nunes, N., Overton, C., Quenby, S., Rai, R., Raine-Fenning, N., Robinson, L., Ross, J., Sizer, A., Small, R., Tan, A., Underwood, M., Kilby, M. D., Boelaert, K., Daniels, J., Thangaratinam, S., Chan, S. Y., & Coomarasamy, A.
- Affiliations
- From the Institute of Metabolism and Systems Research (R.K.D.-S., C.M., M.D.K., K. Boelaert, A.C.), Tommy’s National Centre for Miscarriage Research (R.K.D.-S., A.C.), and the Birmingham Clinical Trials Unit, Institute of Applied Health Research (L.J.M., K.K.S., V.C., S.F.-C.), College of Medical and Dental Sciences, University of Birmingham, the Birmingham Women’s and Children’s NHS Foundation Trust (R.K.D.-S., L.R., M.D.K., A.C.), and University Hospital Birmingham (P.G., R.S.), Birmingham, the...
- Cancer Research UK Clinical Trials Unit (GB)
- University of Oxford (GB)
- Miscarriage Association (GB)
- University Hospital Coventry (GB)
- Burnley General Teaching Hospital (GB)
- St Mary's Hospital (GB)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- University College Hospital (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- University Hospital Crosshouse (GB)
- Bolton NHS Foundation Trust (GB)
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- University Hospitals Bristol NHS Foundation Trust (GB)
- Imperial College Healthcare NHS Trust (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Shrewsbury and Telford Hospital NHS Trust (GB)
- Queen Mary University of London (GB)
- University of Nottingham (GB)
- National University of Singapore (SG)
- ORCID
- Middleton, Lee J.
- Sunner, Kirandeep K.
- Cheed, Versha
- Baker, Krys
- Farrell-Carver, Samantha
- Bender-Atik, Ruth
- Agrawal, Rina
- Bhatia, Kalsang
- Edi-Osagie, Edmond
- Ghobara, Tarek
- Gupta, Pratima
- Jurkovic, Davor
- Khalaf, Yacoub
- MacLean, Marjory
- McCabe, Christopher
- Mulbagal, Khashia
- Nunes, Natalie
- Overton, Caroline
- Quenby, Siobhan
- Ross, Jackie
- Sizer, Andrew
- Small, Rachel
- Tan, Alex
- Underwood, Martyn
- Kilby, Mark D.
- Boelaert, Kristien
- Daniels, Jane
- Thangaratinam, Shakila
- Chan, Shiao Y.
- Coomarasamy, Arri
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-04-04
- Volume
- 380
- Issue
- 14
- Pages
- 1316-1325
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2925290838
- Cited by
- 303
- References
- 6
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 35 · 2023: 45 · 2022: 65 · 2021: 40 · 2020: 50 · 2019: 27
- FWCI
- 36.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- Bristol Research (University of Bristol) (publishedVersion, other-oa)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- Funders
- Efficacy and Mechanism Evaluation Programme (09/100/10)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Keywords
- levothyroxine, thyroid peroxidase antibodies, thyroid autoantibodies, live birth rate, miscarriage, preterm birth, infertility, pregnancy outcomes, euthyroid women, adverse drug reactions
- MeSH terms
- Abortion, Spontaneous, Adult, Autoantibodies, Double-Blind Method, Female, Humans, Infertility, Female, Iodide Peroxidase, Pregnancy, Thyrotropin, Thyroxine, Preconception Care, Treatment Failure, Live Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.